Global and United States Metagenomics in Healthcare Market Report & Forecast 2023-2028

Report ID: 1825656 | Published Date: Jan 2025 | No. of Page: 87 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Metagenomics in Healthcare Revenue in Metagenomics in Healthcare Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Metagenomics in Healthcare Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Metagenomics in Healthcare Market Size for the Year 2017-2028
        1.2.2 Global Metagenomics in Healthcare Market Size for the Year 2017-2028
    1.3 Metagenomics in Healthcare Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Metagenomics in Healthcare in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Metagenomics in Healthcare Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Metagenomics in Healthcare Market Dynamics
        1.4.1 Metagenomics in Healthcare Industry Trends
        1.4.2 Metagenomics in Healthcare Market Drivers
        1.4.3 Metagenomics in Healthcare Market Challenges
        1.4.4 Metagenomics in Healthcare Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Metagenomics in Healthcare by Type
    2.1 Metagenomics in Healthcare Market Segment by Type
        2.1.1 Sample Extraction Kits
        2.1.2 Metagenomics Kits
    2.2 Global Metagenomics in Healthcare Market Size by Type (2017, 2022 & 2028)
    2.3 Global Metagenomics in Healthcare Market Size by Type (2017-2028)
    2.4 United States Metagenomics in Healthcare Market Size by Type (2017, 2022 & 2028)
    2.5 United States Metagenomics in Healthcare Market Size by Type (2017-2028)
3 Metagenomics in Healthcare by Application
    3.1 Metagenomics in Healthcare Market Segment by Application
        3.1.1 Pharmaceutical Industries
        3.1.2 Biotechnology Companies
        3.1.3 Pathology Laboratories
        3.1.4 Academic and Research Laboratories
        3.1.5 Others
    3.2 Global Metagenomics in Healthcare Market Size by Application (2017, 2022 & 2028)
    3.3 Global Metagenomics in Healthcare Market Size by Application (2017-2028)
    3.4 United States Metagenomics in Healthcare Market Size by Application (2017, 2022 & 2028)
    3.5 United States Metagenomics in Healthcare Market Size by Application (2017-2028)
4 Global Metagenomics in Healthcare Competitor Landscape by Company
    4.1 Global Metagenomics in Healthcare Market Size by Company
        4.1.1 Top Global Metagenomics in Healthcare Companies Ranked by Revenue (2021)
        4.1.2 Global Metagenomics in Healthcare Revenue by Player (2017-2022)
    4.2 Global Metagenomics in Healthcare Concentration Ratio (CR)
        4.2.1 Metagenomics in Healthcare Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Metagenomics in Healthcare in 2021
        4.2.3 Global Metagenomics in Healthcare Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Metagenomics in Healthcare Headquarters, Revenue in Metagenomics in Healthcare Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Metagenomics in Healthcare Headquarters and Area Served
        4.3.2 Global Metagenomics in Healthcare Companies Revenue in Metagenomics in Healthcare Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Metagenomics in Healthcare Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Metagenomics in Healthcare Market Size by Company
        4.5.1 Top Metagenomics in Healthcare Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Metagenomics in Healthcare Revenue by Players (2020, 2021 & 2022)
5 Global Metagenomics in Healthcare Market Size by Region
    5.1 Global Metagenomics in Healthcare Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Metagenomics in Healthcare Market Size by Region (2017-2028)
        5.2.1 Global Metagenomics in Healthcare Market Size by Region: 2017-2022
        5.2.2 Global Metagenomics in Healthcare Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Metagenomics in Healthcare Market Size YoY Growth 2017-2028
        6.1.2 North America Metagenomics in Healthcare Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Metagenomics in Healthcare Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Metagenomics in Healthcare Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Metagenomics in Healthcare Market Size YoY Growth 2017-2028
        6.3.2 Europe Metagenomics in Healthcare Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Metagenomics in Healthcare Market Size YoY Growth 2017-2028
        6.4.2 Latin America Metagenomics in Healthcare Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Metagenomics in Healthcare Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Metagenomics in Healthcare Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Illumina
        7.1.1 Illumina Company Details
        7.1.2 Illumina Business Overview
        7.1.3 Illumina Metagenomics in Healthcare Introduction
        7.1.4 Illumina Revenue in Metagenomics in Healthcare Business (2017-2022)
        7.1.5 Illumina Recent Development
    7.2 QIAGEN
        7.2.1 QIAGEN Company Details
        7.2.2 QIAGEN Business Overview
        7.2.3 QIAGEN Metagenomics in Healthcare Introduction
        7.2.4 QIAGEN Revenue in Metagenomics in Healthcare Business (2017-2022)
        7.2.5 QIAGEN Recent Development
    7.3 PerkinElmer
        7.3.1 PerkinElmer Company Details
        7.3.2 PerkinElmer Business Overview
        7.3.3 PerkinElmer Metagenomics in Healthcare Introduction
        7.3.4 PerkinElmer Revenue in Metagenomics in Healthcare Business (2017-2022)
        7.3.5 PerkinElmer Recent Development
    7.4 Thermo Fisher Scientific
        7.4.1 Thermo Fisher Scientific Company Details
        7.4.2 Thermo Fisher Scientific Business Overview
        7.4.3 Thermo Fisher Scientific Metagenomics in Healthcare Introduction
        7.4.4 Thermo Fisher Scientific Revenue in Metagenomics in Healthcare Business (2017-2022)
        7.4.5 Thermo Fisher Scientific Recent Development
    7.5 Oxford Nanopore Technologies
        7.5.1 Oxford Nanopore Technologies Company Details
        7.5.2 Oxford Nanopore Technologies Business Overview
        7.5.3 Oxford Nanopore Technologies Metagenomics in Healthcare Introduction
        7.5.4 Oxford Nanopore Technologies Revenue in Metagenomics in Healthcare Business (2017-2022)
        7.5.5 Oxford Nanopore Technologies Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Metagenomics in Healthcare Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Metagenomics in Healthcare Market Trends
    Table 3. Metagenomics in Healthcare Market Drivers
    Table 4. Metagenomics in Healthcare Market Challenges
    Table 5. Metagenomics in Healthcare Market Restraints
    Table 6. Global Metagenomics in Healthcare Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Metagenomics in Healthcare Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Metagenomics in Healthcare Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Metagenomics in Healthcare Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Metagenomics in Healthcare Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Metagenomics in Healthcare Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Metagenomics in Healthcare Revenue Share by Player, 2017-2022
    Table 13. Global Metagenomics in Healthcare Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Metagenomics in Healthcare by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metagenomics in Healthcare as of 2021)
    Table 15. Top Players of Metagenomics in Healthcare in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Metagenomics in Healthcare Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Metagenomics in Healthcare Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Metagenomics in Healthcare Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Metagenomics in Healthcare Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Metagenomics in Healthcare Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Metagenomics in Healthcare Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Metagenomics in Healthcare Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Metagenomics in Healthcare Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Metagenomics in Healthcare Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Metagenomics in Healthcare Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Metagenomics in Healthcare Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Metagenomics in Healthcare Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Metagenomics in Healthcare Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Illumina Company Details
    Table 31. Illumina Business Overview
    Table 32. Illumina Metagenomics in Healthcare Product
    Table 33. Illumina Revenue in Metagenomics in Healthcare Business (2017-2022) & (US$ Million)
    Table 34. Illumina Recent Development
    Table 35. QIAGEN Company Details
    Table 36. QIAGEN Business Overview
    Table 37. QIAGEN Metagenomics in Healthcare Product
    Table 38. QIAGEN Revenue in Metagenomics in Healthcare Business (2017-2022) & (US$ Million)
    Table 39. QIAGEN Recent Development
    Table 40. PerkinElmer Company Details
    Table 41. PerkinElmer Business Overview
    Table 42. PerkinElmer Metagenomics in Healthcare Product
    Table 43. PerkinElmer Revenue in Metagenomics in Healthcare Business (2017-2022) & (US$ Million)
    Table 44. PerkinElmer Recent Development
    Table 45. Thermo Fisher Scientific Company Details
    Table 46. Thermo Fisher Scientific Business Overview
    Table 47. Thermo Fisher Scientific Metagenomics in Healthcare Product
    Table 48. Thermo Fisher Scientific Revenue in Metagenomics in Healthcare Business (2017-2022) & (US$ Million)
    Table 49. Thermo Fisher Scientific Recent Development
    Table 50. Oxford Nanopore Technologies Company Details
    Table 51. Oxford Nanopore Technologies Business Overview
    Table 52. Oxford Nanopore Technologies Metagenomics in Healthcare Product
    Table 53. Oxford Nanopore Technologies Revenue in Metagenomics in Healthcare Business (2017-2022) & (US$ Million)
    Table 54. Oxford Nanopore Technologies Recent Development
    Table 55. Research Programs/Design for This Report
    Table 56. Key Data Information from Secondary Sources
    Table 57. Key Data Information from Primary Sources
List of Figures
    Figure 1. Metagenomics in Healthcare Product Picture
    Figure 2. Global Metagenomics in Healthcare Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Metagenomics in Healthcare Market Size 2017-2028 (US$ Million)
    Figure 4. United States Metagenomics in Healthcare Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Metagenomics in Healthcare Market Size 2017-2028 (US$ Million)
    Figure 6. United States Metagenomics in Healthcare Market Share in Global 2017-2028
    Figure 7. Metagenomics in Healthcare Report Years Considered
    Figure 8. Product Picture of Sample Extraction Kits
    Figure 9. Product Picture of Metagenomics Kits
    Figure 10. Global Metagenomics in Healthcare Market Share by Type in 2022 & 2028
    Figure 11. Global Metagenomics in Healthcare Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Metagenomics in Healthcare Market Share by Type (2017-2028)
    Figure 13. United States Metagenomics in Healthcare Market Share by Type in 2022 & 2028
    Figure 14. United States Metagenomics in Healthcare Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Metagenomics in Healthcare Market Share by Type (2017-2028)
    Figure 16. Product Picture of Pharmaceutical Industries
    Figure 17. Product Picture of Biotechnology Companies
    Figure 18. Product Picture of Pathology Laboratories
    Figure 19. Product Picture of Academic and Research Laboratories
    Figure 20. Product Picture of Others
    Figure 21. Global Metagenomics in Healthcare Market Share by Application in 2022 & 2028
    Figure 22. Global Metagenomics in Healthcare Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Metagenomics in Healthcare Market Share by Application (2017-2028)
    Figure 24. United States Metagenomics in Healthcare Market Share by Application in 2022 & 2028
    Figure 25. United States Metagenomics in Healthcare Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Metagenomics in Healthcare Market Share by Application (2017-2028)
    Figure 27. North America Metagenomics in Healthcare Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Metagenomics in Healthcare Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Metagenomics in Healthcare Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Metagenomics in Healthcare Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Metagenomics in Healthcare Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E Metagenomics in Healthcare Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Illumina Revenue Growth Rate in Metagenomics in Healthcare Business (2017-2022)
    Figure 56. QIAGEN Revenue Growth Rate in Metagenomics in Healthcare Business (2017-2022)
    Figure 57. PerkinElmer Revenue Growth Rate in Metagenomics in Healthcare Business (2017-2022)
    Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Metagenomics in Healthcare Business (2017-2022)
    Figure 59. Oxford Nanopore Technologies Revenue Growth Rate in Metagenomics in Healthcare Business (2017-2022)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Illumina
QIAGEN
PerkinElmer
Thermo Fisher Scientific
Oxford Nanopore Technologies
Frequently Asked Questions
Metagenomics in Healthcare report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Metagenomics in Healthcare report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Metagenomics in Healthcare report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports